Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California. Show more
Location: 2269 Chestnut Street, San Francisco, CA, 94123, United States | Website: https://www.hims.com | Industry: Drug Manufacturers - Specialty & Generic | Sector: Healthcare
Market Cap
12.04B
52 Wk Range
$16.05 - $72.98
Previous Close
$53.25
Open
$52.21
Volume
22,225,038
Day Range
$50.70 - $55.10
Enterprise Value
11.94B
Cash
1.145B
Avg Qtr Burn
N/A
Insider Ownership
10.66%
Institutional Own.
89.01%
Qtr Updated
06/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|